Möchten Sie immer auf dem neuesten Stand bleiben?

Erstellen Sie noch heute ein Leserkonto, um die Branchen und Unternehmen zu verfolgen, die Sie interessieren, und passen Sie Ihr Nachrichten-Dashboard an.

Beim Leserkonto Anmelden Leserkonto Erstellen

12. Mai 2026 06:00 ET | Quelle: Addition Therapeutics, Inc

Addition Therapeutics Presents Preclinical Proof-of-Concept Data at American Society of Gene & Cell Therapy (ASGCT) 29th Annual Meeting

Addition Therapeutics presents preclinical proof-of-concept data at American Society of Gene & Cell Therapy (ASGCT) 29th Annual Meeting in Boston.
27. April 2026 16:30 ET | Quelle: Addition Therapeutics, Inc

Addition Therapeutics Announces Multiple Oral and Poster Presentations at the American Society of Gene & Cell Therapy (ASGCT) 29th Annual Meeting

Addition Therapeutics announces multiple oral and poster presentations at the upcoming ASGCT Annual Meeting, May 11-15, 2026, in Boston.
17. Dezember 2025 07:00 ET | Quelle: Addition Therapeutics, Inc

Addition Therapeutics Announces $100 Million in Funding and Significant Progress Advancing Mission to Fulfill Promise of Genomic Medicine for Chronic and Rare Diseases

Addition Therapeutics announces $100 million in funding and significant progress advancing its mission to fulfill the promise of genomic medicine.